New approvals to revolutionise myelofibrosis treatment landscape across 8MM: GlobalData
The MF market will grow from $2.39 billion in 2021 to $2.89 billion in 2031 across the 8MM, registering a compound annual growth…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jakafi
Ruxolitinib (Jakafi) does not prevent complications due to COVID-19 associated cytokine storm: Study
There was no reduction in the proportion of patients receiving ruxolitinib plus SoC who experienced severe complications including…